Land: Australia
Språk: engelsk
Kilde: APVMA (Australian Pesticides and Veterinary Medicines Authority)
ELTENAC
INTERVET AUSTRALIA PTY LIMITED
eltenac(50mg/mL)
PARENTERAL LIQUID/SOLUTION/SUSPENSION
ELTENAC ANTI-INFLAMMATORY-NON-STEROID Active 50.0 mg/ml
20mL; 50mL
VM - Veterinary Medicine
INTERVET AUSTRALIA
HORSE | COLT | DONKEY | ENDURANCE HORSE | FILLY | FOAL | GELDING | HIGH PERFORMANCE HORSES | HORSES AT STUD | MARE | PACER | POL
MUSCULOSKELETAL SYSTEM
ANTI-INFLAMMATORY AGENT | ENDOTOXAEMIA | MUSCULOSKELETAL CONDITIONS | OEDEMA | ANTIPYRETIC | ARTHRITIS | ARTHROSIS | BONE SORENESS | BRUISING | BURSITIS | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | INFLAMMATORY RHEUMATIC ARTHRIT | JOINT DISEASE | LIGAMENT SPRAINS | MUSCLE SORENESS | OSTEITIS | OSTEOARTHRITIS | PHYSIOLOGICAL OF THE MAMMARY G | PLATELET ACTIVITY | RHEUMATISM | SPRAINS | STRAINS | TENDON AND LIGAMENT SPRAINS | TENDON SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE | TRAUMATIC SWELLING
Poison schedule: 4; Withholding period: WHP: Horses:Not to be used in horses i ntended for human consumption.; Host/pest details: HORSE: [ANTI-INFLAMMATORY AGENT, ENDOTOXAEMIA, MUSCULOSKELETAL CONDITIONS, OEDEMA]; Poison schedule: 4; Withholding period: ; Host/pest details: HORSE: [ANTI-INFLAMMATORY AGENT, ENDOTOXAEMIA, MUSCULOSKELETAL CONDITIONS, OEDEMA]; For use in the alleviation of inflammation associated with musculoskeletal disorders and control of post- operative swelling, oedema and endotoxaemia in horses.NOT TO BE USED in food producing animals. DO NOT USE IN: dehydrated, hypovolemic or hypotensive animals; breeding horses; pregnant mares; combination with other NSAID; combination with potentially nephrotoxic drugs. DO NOT administer by intramuscular inj.
Registered
2023-07-01
File Name: 51552_0602c.doc Prepared By: L. Wirth Preparation Date: 4/6/2002 Last Revised: 11/10/2000 Schering-Plough Label & Printer Specifications: CCP 02/019 Version: 1 (4/6/2002) Page 1 of 6 TELZENAC (20 mL and 50 mL PRIMARY PACK CARTON - MAIN PANEL PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY TELZENAC INJECTABLE FOR HORSES ACTIVE CONSTITUENT: ELTENAC 50 mg/mL_ _ For use in the alleviation of inflammation associated with musculoskeletal disorders and control of post-operative swelling, oedema and endotoxaemia in horses. 20ML 50ML SCHERING-PLOUGH ANIMAL HEALTH Info PEST Verified File Name: 51552_0602c.doc Prepared By: L. Wirth Preparation Date: 4/6/2002 Last Revised: 11/10/2000 Schering-Plough Label & Printer Specifications: CCP 02/019 Version: 1 (4/6/2002) Page 2 of 6 TELZENAC (20 mL and 50 mL) PRIMARY PACK CARTON ANCILLARY PANELS READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT DIRECTIONS FOR USE: NOT TO BE USED IN FOOD PRODUCING ANIMALS. DO NOT USE IN DEHYDRATED, HYPOVOLEMIC OR HYPOTENSIVE ANIMALS. DO NOT USE IN BREEDING HORSES. DO NOT USE IN PREGNANT MARES. DO NOT USE IN COMBINATION WITH OTHER NSAID. DO NOT USE IN COMBINATION WITH POTENTIALLY NEPHROTOXIC DRUGS. DO NOT ADMINISTER BY INTRAMUSCULAR INJECTION. PRECAUTION FOR USE IN HORSES ONLY SEE PRODUCT LEAFLET FOR FULL DETAILS DOSAGE AND ADMINISTRATION: USE CONTENTS WITHIN 4 WEEKS OF BREACHING THE VIAL. 0.5 mg/kg (1 mL/100 kg) injected intravenously, once daily for up to 5 days according to clinical response. SWAB STOPPER BEFORE REMOVING EACH DOSE. USE A DRY STERILE NEEDLE AND SYRINGE. IF USED IN PERFORMANCE ANIMALS, THE REGULATIONS OF THE RELEVANT AUTHORITIES REGARDING MEDICATION SHOULD BE OBSERVED. MEAT WITHHOLDING PERIOD (HORSES): NOT TO BE USED IN HORSES INTENDED FOR HUMAN CONSUMPTION. SAFETY INFORMATION This product may irritate the skin and eyes. Avoid contact with skin, eyes and clothes. FIRST AID IF POISONING OCCURS, CONTACT A DOCTOR OR POISONS INFORMATION CENTRE (PHONE 131126). IF SKI Les hele dokumentet